Delivery Order SPE2DB22D2007-SPE2DB25FJ3JE
- Not listed
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,655.53 firm-fixed-price delivery order is for the supply of 100 units of Quillichew ER 20 mg chewable tablets. The contract has a performance period ending on June 11, 2025. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $1,185.60 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of QUILLICHEW ER 30 MG CHEW TAB 100S, a pharmaceutical product. The contract has a firm fixed price structure and an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,590,875 units of QuillicheW ER 20 mg chewable tablets. The contract has a firm fixed price of $2,997.27 and a completion date of May 14, 2024. This order was placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,434.50 Firm Fixed Price delivery order contract is for the supply of QUILLICHEW ER 20 MG CHEW TAB 100S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,088.72 to AmerisourceBergen Drug Corp for Quillichew ER Chew Tabs 40mg, a medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,040.05, is for the delivery of QUILLICHEW ER CHEW TABS 20MG and has a completion date of March 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements indicated. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply QuillIchew ER 20 mg chewable tablets in 100-count bottles. The $1,380.05 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical as the prime contractor, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,860.08, is for the delivery of QUILLICHEW ER 20 MG CHEW TAB 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3JEDelivery Order
On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and serves as a major distributor of medical supplies to federal agencies. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications and medical products to support military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a pharmaceutical vendor for the Defense Health Agency and other government healthcare systems, with capabilities spanning specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/25/25 |